FDA inspection
Arevipharma GmbH: FDA inspection ending Sep 16, 2019
FDA inspection 1141793 · No Action Indicated (NAI) · Radebeul
Key facts
| Inspection ID | 1141793 |
|---|---|
| Firm | Arevipharma GmbH |
| FEI number | 1000505976 |
| Address | Meisner Str. 35 |
| City | Radebeul |
| Country | Germany |
| Fiscal year | 2019 |
| Inspection end date | Sep 16, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data